https://www.marketscreener.com/quote/stock/ROIVANT-SCIENCES-LTD-116111641/news/Roivant-and-Priovant-Therapeutics-Announce-Positive-Results-from-the-Phase-2-Study-for-Brepocitinib-46338478/?utm_source=telegram&utm_medium=social&utm_campaign=share